Skip navigation
Skip navigation

Data Protection in China: 17 Years after China's WTO Accession

Cheng, Wenting


China introduced dual data protection (both undisclosed information and six-year data exclusivity) for pharmaceutical products from its accession to the WTO. From 2017, a new series of policies proposed up to 12 years of data exclusivity for biologics. The drug negotiation mechanism in China should be considered in evaluating the impacts of these policies on enhanced data protection

CollectionsANU Research Publications
Date published: 2018
Type: Journal article
Source: European Intellectual Property Review (E.I.P.R)


File Description SizeFormat Image
01_Cheng_Data_Protection_in_China%3A_17_2018.pdf326.36 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator